Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Crossref DOI link: https://doi.org/10.1007/s40261-020-00892-9
Published Online: 2020-02-10
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A. http://orcid.org/0000-0002-5104-1158
Text and Data Mining valid from 2020-02-10
Version of Record valid from 2020-02-10
Article History
First Online: 10 February 2020